No images? Click here
MEDTECH
Apollo Therapeutics and the University of Oxford recently announced a collaboration aimed at accelerating drug discovery and development, leveraging Oxford's groundbreaking biomedical research to create new therapeutics for diseases
like cancer and autoimmune disorders.
Spotlight on Spinouts
Dr Michalis Papadakis tells us about his company, Brainomix's, AI stroke technology and the lives they have changed.
Spotlight on consulting services - Cybersecurity
Enhancing national cybersecurity through Oxford University Innovation’s Consulting Services
Oxford University Innovation's Consulting Services team is helping to strengthen global cybersecurity resilience through the Cybersecurity Capacity Maturity Model to help nations assess and enhance their cybersecurity capabilities.
Discover EIT Pathogena - a new genomic analysis tool
EIT Pathogena is a cutting-edge genomic analysis platform for academics and public health professionals around the world to help fight infectious diseases. Discover how the team at Oxford University Innovation supported the creation of this innovative tool.
Oxford experts develop new online therapies for anxiety and PTSD
Experts from the University of Oxford have developed four innovative internet-based therapies that provide essential support for individuals suffering from social anxiety disorder and post-traumatic stress disorder, helping to bridge the gap in mental health care.
Discover OUI Start-up Incubator's newest cohort, featuring 20 teams of entrepreneurs ready to make their mark by creating a new company.
CLEAN TECH
OXCCU - Pioneering the future of clean energy and global transition
The OUI team recently joined the launch of OXCCU's ground breaking demonstration plant, OX1, the world's first facility to convert carbon dioxide and hydrogen directly into sustainable aviation fuel through a streamlined process.
Join the Oxford Innovation Society (OIS) to meet our network of industry partners, academic founders, companies and investors. Our next event is November 7th in central Oxford, Shaping the Future: Oxford's Innovation Ecosystem.
Contact Louise on marketing@innovation.ox.ac.uk for more details.
MatchBio spinout set to revolutionise immunotherapy
MatchBio, a spinout founded by Professors Omer Dushek and Anton van der Merwe, aims to revolutionise immunotherapy by enhancing CAR T therapy to improve sensitivity and specificity in detecting low-antigen cancer cells, thereby reducing relapse rates and expanding treatment options for various cancers.
Mixergy is paving the way for a smarter, sustainable energy future
Mixergy, an Oxford University spinout, is revolutionising the energy sector with its smart hot water cylinders that enhance grid flexibility and support the integration of renewable energy sources.
Remembering Professor Chris Redman
The recent passing of Professor Chris Redman, co-developer of the Dawes-Redman Cardiotocography analysis system, is a profound loss for the field of obstetrics. Chris's pioneering work transformed foetal health monitoring and established the system as the gold standard for clinical assessments worldwide.
Clinical Outcomes Assessments
Transforming lives: Clinical Assessments for vasculitis Patients
Vasculitis is the name of a group of conditions that cause inflammation of the blood vessels. It affects about 14,000 people in the UK each year. OUI's Clinical Outcome Assessments are enhancing the measurement of quality of life and treatment impact for patients suffering with vasculitis conditions.
Technologies to License
A system to control optical signals with optical signals
The invention addresses a huge challenge in the field of photonics - finding a way to control one wavelength of light using another.
Stable high energy density materials for lithium-ion batteries
Oxford researchers have developed a method to produce dendritic cells from iPS cells that display a mature ‘adult phenotype’, substantially increasing their potential effectiveness in immunotherapy.
Job Opportunities
